Star Equity Holdings, Inc. (STRR)
USD 2.0
(-0.99%)
USD 2.0
(-0.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.42 Million USD | -67.82% |
| 2022 | 10.62 Million USD | 24.66% |
| 2021 | 8.52 Million USD | -12.89% |
| 2020 | 9.78 Million USD | 37.9% |
| 2019 | 7.09 Million USD | 31.38% |
| 2018 | 5.4 Million USD | -1.8% |
| 2017 | 5.5 Million USD | -8.12% |
| 2016 | 5.98 Million USD | 36.66% |
| 2015 | 4.38 Million USD | 20.23% |
| 2014 | 3.64 Million USD | -6.11% |
| 2013 | 3.88 Million USD | -22.05% |
| 2012 | 4.97 Million USD | -19.41% |
| 2011 | 6.17 Million USD | 13.73% |
| 2010 | 5.43 Million USD | -15.15% |
| 2009 | 6.4 Million USD | 28.61% |
| 2008 | 4.97 Million USD | -8.74% |
| 2007 | 5.45 Million USD | -6.91% |
| 2006 | 5.86 Million USD | 14.1% |
| 2005 | 5.13 Million USD | -26.42% |
| 2004 | 6.98 Million USD | 88.17% |
| 2003 | 3.7 Million USD | -35.51% |
| 2002 | 5.75 Million USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 4.72 Million USD | 38.01% |
| 2024 Q2 | 5.78 Million USD | 22.65% |
| 2023 Q4 | 3.42 Million USD | -19.4% |
| 2023 FY | 3.42 Million USD | -67.82% |
| 2023 Q1 | 10.04 Million USD | -5.5% |
| 2023 Q3 | 4.24 Million USD | -4.37% |
| 2023 Q2 | 4.43 Million USD | -55.82% |
| 2022 Q4 | 10.62 Million USD | -18.66% |
| 2022 Q3 | 13.06 Million USD | 16.47% |
| 2022 Q1 | 10.28 Million USD | 20.67% |
| 2022 FY | 10.62 Million USD | 24.66% |
| 2022 Q2 | 11.21 Million USD | 9.04% |
| 2021 FY | 8.52 Million USD | -12.89% |
| 2021 Q2 | 12.02 Million USD | 22.18% |
| 2021 Q3 | 9.98 Million USD | -16.97% |
| 2021 Q4 | 8.52 Million USD | -14.58% |
| 2021 Q1 | 9.83 Million USD | 0.52% |
| 2020 Q1 | 6.61 Million USD | -6.76% |
| 2020 Q4 | 9.78 Million USD | 8.74% |
| 2020 Q3 | 9 Million USD | 17.83% |
| 2020 Q2 | 7.63 Million USD | 15.43% |
| 2020 FY | 9.78 Million USD | 37.9% |
| 2019 FY | 7.09 Million USD | 31.38% |
| 2019 Q1 | 5.48 Million USD | 1.5% |
| 2019 Q2 | 5.78 Million USD | 5.43% |
| 2019 Q3 | 8.17 Million USD | 41.48% |
| 2019 Q4 | 7.09 Million USD | -13.23% |
| 2018 Q3 | 5.88 Million USD | -1.8% |
| 2018 Q1 | 5.75 Million USD | 4.62% |
| 2018 Q4 | 5.4 Million USD | -8.19% |
| 2018 Q2 | 5.99 Million USD | 4.12% |
| 2018 FY | 5.4 Million USD | -1.8% |
| 2017 Q3 | 5.9 Million USD | -0.08% |
| 2017 FY | 5.5 Million USD | -8.12% |
| 2017 Q2 | 5.9 Million USD | -0.57% |
| 2017 Q4 | 5.5 Million USD | -6.81% |
| 2017 Q1 | 5.94 Million USD | -0.75% |
| 2016 Q3 | 5.9 Million USD | 1.77% |
| 2016 FY | 5.98 Million USD | 36.66% |
| 2016 Q4 | 5.98 Million USD | 1.32% |
| 2016 Q2 | 5.8 Million USD | 20.76% |
| 2016 Q1 | 4.8 Million USD | 9.75% |
| 2015 Q3 | 4.32 Million USD | 7.69% |
| 2015 Q2 | 4.01 Million USD | 9.82% |
| 2015 FY | 4.38 Million USD | 20.23% |
| 2015 Q1 | 3.65 Million USD | 0.36% |
| 2015 Q4 | 4.38 Million USD | 1.29% |
| 2014 Q2 | 3.49 Million USD | -6.92% |
| 2014 FY | 3.64 Million USD | -6.11% |
| 2014 Q4 | 3.64 Million USD | 2.85% |
| 2014 Q3 | 3.54 Million USD | 1.37% |
| 2014 Q1 | 3.75 Million USD | -3.25% |
| 2013 Q1 | 4.86 Million USD | -2.23% |
| 2013 FY | 3.88 Million USD | -22.05% |
| 2013 Q4 | 3.88 Million USD | -12.06% |
| 2013 Q3 | 4.41 Million USD | -5.97% |
| 2013 Q2 | 4.69 Million USD | -3.59% |
| 2012 FY | 4.97 Million USD | -19.41% |
| 2012 Q1 | 6.06 Million USD | -1.78% |
| 2012 Q4 | 4.97 Million USD | -24.25% |
| 2012 Q3 | 6.57 Million USD | 5.22% |
| 2012 Q2 | 6.24 Million USD | 2.95% |
| 2011 Q2 | 6.06 Million USD | 9.62% |
| 2011 Q4 | 6.17 Million USD | 5.3% |
| 2011 Q1 | 5.52 Million USD | 1.79% |
| 2011 FY | 6.17 Million USD | 13.73% |
| 2011 Q3 | 5.86 Million USD | -3.2% |
| 2010 Q2 | 6.15 Million USD | -5.86% |
| 2010 Q4 | 5.43 Million USD | -10.23% |
| 2010 FY | 5.43 Million USD | -15.15% |
| 2010 Q1 | 6.54 Million USD | 2.17% |
| 2010 Q3 | 6.05 Million USD | -1.74% |
| 2009 Q3 | 6.74 Million USD | -2.94% |
| 2009 Q4 | 6.4 Million USD | -5.01% |
| 2009 FY | 6.4 Million USD | 28.61% |
| 2009 Q2 | 6.94 Million USD | 9.27% |
| 2009 Q1 | 6.35 Million USD | 27.66% |
| 2008 Q1 | 5.8 Million USD | 6.4% |
| 2008 Q4 | 4.97 Million USD | -13.43% |
| 2008 Q3 | 5.75 Million USD | 1.73% |
| 2008 FY | 4.97 Million USD | -8.74% |
| 2008 Q2 | 5.65 Million USD | -2.62% |
| 2007 FY | 5.45 Million USD | -6.91% |
| 2007 Q4 | 5.45 Million USD | 7.81% |
| 2007 Q3 | 5.06 Million USD | -15.95% |
| 2007 Q2 | 6.02 Million USD | -11.48% |
| 2007 Q1 | 6.8 Million USD | 16.06% |
| 2006 FY | 5.86 Million USD | 14.1% |
| 2006 Q2 | 5.19 Million USD | 25.53% |
| 2006 Q3 | 5.81 Million USD | 11.88% |
| 2006 Q1 | 4.13 Million USD | -19.45% |
| 2006 Q4 | 5.86 Million USD | 0.86% |
| 2005 Q2 | 8.87 Million USD | 9.76% |
| 2005 FY | 5.13 Million USD | -26.42% |
| 2005 Q1 | 8.08 Million USD | 15.8% |
| 2005 Q3 | 6.46 Million USD | -27.16% |
| 2005 Q4 | 5.13 Million USD | -20.52% |
| 2004 Q1 | 3.74 Million USD | 0.0% |
| 2004 Q2 | 4.4 Million USD | 17.58% |
| 2004 Q3 | 5.21 Million USD | 18.29% |
| 2004 FY | 6.98 Million USD | 88.17% |
| 2004 Q4 | 6.98 Million USD | 33.95% |
| 2003 FY | 3.7 Million USD | -35.51% |
| 2002 FY | 5.75 Million USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aspira Women's Health Inc. | 227 Thousand USD | -1406.608% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -18402.489% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -339.85% |
| Standard BioTools Inc. | 20.53 Million USD | 83.344% |
| Inotiv, Inc. | 56.1 Million USD | 93.904% |
| Prenetics Global Limited | 3.12 Million USD | -9.378% |
| Neuronetics, Inc. | 8.09 Million USD | 57.741% |
| Castle Biosciences, Inc. | 7.94 Million USD | 56.938% |
| Psychemedics Corporation | 1.00 USD | -341999900.0% |
| RadNet, Inc. | 1.00 USD | -341999900.0% |
| Exact Sciences Corporation | 127.47 Million USD | 97.317% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 99.101% |
| iSpecimen Inc. | - USD | -Infinity% |
| OpGen, Inc. | 1.00 USD | -341999900.0% |
| Exagen Inc. | 2.87 Million USD | -19.122% |
| Bionano Genomics, Inc. | 22.89 Million USD | 85.061% |
| CareDx, Inc | 19.47 Million USD | 82.435% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | 89.333% |
| Guardant Health, Inc. | 61.94 Million USD | 94.479% |
| Biodesix, Inc. | 1.4 Million USD | -144.286% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -200.588% |
| Precipio, Inc. | 384 Thousand USD | -790.625% |
| Natera, Inc. | 40.75 Million USD | 91.609% |
| Fulgent Genetics, Inc. | 5.82 Million USD | 41.308% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| 23andMe Holding Co. | 12.46 Million USD | 72.563% |
| OPKO Health, Inc. | 65.69 Million USD | 94.794% |
| Personalis, Inc. | 5.66 Million USD | 39.587% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -936.279% |
| T2 Biosystems, Inc. | 4.81 Million USD | 29.031% |
| Neogen Corporation | 189.26 Million USD | 98.193% |
| Myriad Genetics, Inc. | 20.1 Million USD | 82.985% |
| ICON Public Limited Company | 1.00 USD | -341999900.0% |
| NeoGenomics, Inc. | 24.15 Million USD | 85.842% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 0.0% |
| MDxHealth SA | 2.77 Million USD | -23.066% |
| Prenetics Global Limited | 3.12 Million USD | -9.378% |
| Illumina, Inc. | 587 Million USD | 99.417% |
| DarioHealth Corp. | 5.06 Million USD | 32.438% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -30.392% |
| Medpace Holdings, Inc. | 1.00 USD | -341999900.0% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -457.332% |
| Trinity Biotech plc | 19.93 Million USD | 82.843% |
| Sotera Health Company | 51.98 Million USD | 93.421% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -18402.489% |